STOCK TITAN
  1. Home
  2. Sec-filings
  3. PGEN
  4. [144] PRECIGEN, INC. SEC Filing

Precigen (PGEN) director plans 185,000-share 2026 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PRECIGEN, INC. (PGEN) is the issuer for which Jeffrey Kindler has filed a notice of proposed sale of restricted securities under Rule 144. The filing covers 185,000 shares of Common Stock, with an indicated aggregate market value of $1,372,700, to be sold through Goldman Sachs & Co. LLC on or after 08/26/2026. These shares were acquired from Precigen as compensation in the form of Restricted Stock Units on various grant dates between 03/09/2023 and 03/13/2026.

Positive

  • None.

Negative

  • None.
Shares proposed to be sold 185,000 shares of Common Stock Number of shares covered by the Rule 144 notice
Aggregate market value of securities to be sold $1,372,700 Stated value for the 185,000 shares in the proposed sale
Shares outstanding 358,035,247 shares of Common Stock Shares outstanding for Precigen, Inc.
Planned sale date 08/26/2026 Date from which sales under this notice may commence
Compensation shares acquired 03/09/2023 41,874 shares Common Stock acquired as compensation via Restricted Stock Units
Compensation shares acquired 03/13/2026 71,839 shares Common Stock acquired as compensation via Restricted Stock Units
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Units financial
"Acquired as compensation -- Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
aggregate market value financial
"185000 | 1372700 | 358035247 | 08/26/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Common Stock financial
"Common Stock | 03/09/2023 | Acquired as compensation"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What does the Form 144 filing disclose for PRECIGEN, INC. (PGEN)?
The filing discloses that Jeffrey Kindler intends to sell 185,000 shares of Precigen Common Stock under Rule 144 through Goldman Sachs & Co. LLC, with an indicated aggregate market value of $1,372,700, starting on or after 08/26/2026.

Who is selling PRECIGEN (PGEN) shares and through which broker?
The seller is Jeffrey Kindler, identified as a Director of Precigen, Inc. The planned Rule 144 sale of Common Stock will be executed through Goldman Sachs & Co. LLC as the broker.

How many PRECIGEN (PGEN) shares are covered by this Rule 144 notice?
The notice covers 185,000 shares of Precigen Common Stock. The filing also notes a related aggregate market value of $1,372,700 for these shares at the time of the notice.

What is the source of the PRECIGEN (PGEN) shares to be sold?
All 185,000 shares to be sold were acquired as compensation from Precigen in the form of Restricted Stock Units, with grant/acquisition dates of 03/09/2023, 03/09/2024, 03/13/2025, 03/13/2026, and 03/10/2026.

How many PRECIGEN (PGEN) shares are outstanding according to the filing?
The filing states that 358,035,247 shares of Precigen Common Stock were outstanding. This figure provides context for the size of the 185,000-share proposed sale.

On which market are the PRECIGEN (PGEN) shares expected to be sold under this Form 144?
The Common Stock is listed with NASD indicated in the filing, and the planned Rule 144 sales are to be executed through Goldman Sachs & Co. LLC on or after 08/26/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR